Ernexa Therapeutics Inc. Deferred Rent Credit
Ernexa Therapeutics Inc. (ERNA) had Deferred Rent Credit of $1.12 million as of 2018-12-31, per its 10-K filed 2020-03-19.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRentCredit · last filed 2020-03-19
- 2018-12-31: Deferred Rent Credit $1.12M.
- 2017-03-31: Deferred Rent Credit $326.00K.
- 2016-12-31: Deferred Rent Credit $371.00K.
- 2016-09-30: Deferred Rent Credit $415.00K.
| Period end | Deferred Rent Credit |
|---|---|
| 2018-12-31 | $1.12M 10-K · filed 2020-03-19 |
| 2017-03-31 | $326.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $371.00K 10-Q · filed 2017-05-04 |
| 2016-09-30 | $415.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $460.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $501.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $541.00K 10-K · filed 2017-03-09 |
| 2015-09-30 | $581.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $621.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $657.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $693.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $729.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $765.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $797.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $829.00K 10-K · filed 2015-03-27 |
| 2013-09-30 | $861.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $893.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $921.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $949.00K 10-K · filed 2014-03-31 |
| 2012-09-30 | $976.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $967.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $868.00K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $756.00K 10-K · filed 2013-03-29 |
| 2011-09-30 | $645.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $568.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |